The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Abstract: Chimeric antigen receptors (CAR) T‐cell therapy is one of the most effective treatments in curing hematologic malignancies. Besides the four CD19 CAR T‐cells therapy recently approved by the US Food and Drug Administration (FDA), CD20 CAR T‐cell therapy is now another effective treatment option for relapsed or refractory non‐Hodgkin lymphoma (NHL). CD20 CAR T‐cell infusion has achieved remarkable clinical outcomes in patients with B‐cell malignancies. This review will cover the current situations, advantages, limitations, prospects, and application of CD20 CAR T‐cell therapy.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies ; day:05 ; month:10 ; year:2022 ; extent:7
ImmunoMedicine ; (05.10.2022) (gesamt 7)
- Creator
-
Tan Su Yin, Elaine
Hu, Yong Xian
Huang, He
- DOI
-
10.1002/imed.1039
- URN
-
urn:nbn:de:101:1-2022100515035970974255
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tan Su Yin, Elaine
- Hu, Yong Xian
- Huang, He
Other Objects (12)
Infections in hematologic malignancy patients treated by CD19 chimeric antigen receptor T‐cell therapy
Engineering better chimeric antigen receptor T cells
Special issue: CAR‐T cell therapy for hematological malignancies
Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
COVID-19 in Hematologic Malignancies: Big Challenges
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
How do commodity futures respond to macroeconomic news?
Study of stability of time-domain features for electromyographic pattern recognition
Infections in hematologic malignancy patients treated by CD19 chimeric antigen receptor T‐cell therapy
Engineering better chimeric antigen receptor T cells
Special issue: CAR‐T cell therapy for hematological malignancies
Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
COVID-19 in Hematologic Malignancies: Big Challenges
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
How do commodity futures respond to macroeconomic news?
Study of stability of time-domain features for electromyographic pattern recognition
Infections in hematologic malignancy patients treated by CD19 chimeric antigen receptor T‐cell therapy
Engineering better chimeric antigen receptor T cells
Special issue: CAR‐T cell therapy for hematological malignancies
Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
COVID-19 in Hematologic Malignancies: Big Challenges
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
How do commodity futures respond to macroeconomic news?